Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/30/2003WO2002086068A3 Methods for producing recombinant coronavirus
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor
05/30/2003WO2002068632A3 Methods to identify mutant cells with altered sialic acid
05/30/2003WO2002068594A3 Opiate receptors
05/30/2003WO2002067856A3 Injection molding of living tissues
05/30/2003WO2002067812A3 Tympanic membrane patch
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof
05/30/2003WO2002030443A3 Regulation of human skin healing
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity
05/30/2003WO2001080760A8 Method for expansion of epithelial stem cells
05/30/2003CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003CA2467819A1 Improvement of viability and function of pancreatic islets
05/30/2003CA2467223A1 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467195A1 Matrix for the production of tissue engineered ligaments, tendons and other tissue
05/30/2003CA2467181A1 Peptides promoting cell adherence, growth and secretion
05/30/2003CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003CA2466903A1 Ectocornea-like sheet and method of constructing the same
05/30/2003CA2466578A1 Methods and devices for the integrated discovery of cell culture environments
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
05/30/2003CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003CA2407302A1 Genes transfection into bony tissues
05/29/2003US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/29/2003US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants
05/29/2003US20030101486 Schizochytrium PKS genes
05/29/2003US20030101468 Unactivated oocytes as cytoplast recipients for nuclear transfer
05/29/2003US20030101465 Universal stem cells
05/29/2003US20030100948 Connective tissue substitutes, method of preparation and uses thereof
05/29/2003US20030100726 Secreted transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100720 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100715 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100713 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100710 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/29/2003US20030100708 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders
05/29/2003US20030100531 8-30 nucleotides with 2' modified sugar moiety targeted to a nucleic acid molecule encoding human Interleukin-15, hybridizes and inhibits expression; anticancer agents and treating autoimmune diseases
05/29/2003US20030100530 Thyroid stimulating hormone sensitive cell that overexpresses pituitary tumor transforming gene in response to thyroid stimulating hormone
05/29/2003US20030100528 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof
05/29/2003US20030100527 Immunostimulatory nucleic acid molecules for activating dendritic cells
05/29/2003US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy
05/29/2003US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100503 Neurogenic compositions and methods
05/29/2003US20030100497 For stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100125 Filtering particles from liquid sample; obtain fluid sample, deposit on filter, determine time it took for fluid to pass through filter, compare to control
05/29/2003US20030100109 In vitro propagation of plant seeds; prepare nutrient broth ocontaing plant growth regulators, inoculate with explant, propagate and recover cultured cells
05/29/2003US20030100108 Matrix for the production of tissue engineered ligaments, tendons and other tissue
05/29/2003US20030100107 Compositions and methods for generating differentiated human cells
05/29/2003US20030100095 New human cathepsin
05/29/2003US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
05/29/2003US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay
05/29/2003US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders
05/29/2003US20030100082 Isolation of proanthocyanidins from a flavonoid- producing cell; obtain flavonoid producing cell, culture, ferment proanthocyanidins, extract and fractionate proanthocyanidins
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100073 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
05/29/2003US20030100070 Kunitz domain polypeptide Zkun11
05/29/2003US20030100065 Enzymatic polypeptide for use as tool in the fermentation of alcohols
05/29/2003US20030100063 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases
05/29/2003US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030100059 Novel cell-based assays for G-protein-coupled receptor-mediated activities
05/29/2003US20030100053 Nucleotide sequences coding polypeptide for use in the treatment of tumor disorders
05/29/2003US20030100052 Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease
05/29/2003US20030100045 Nucleotide sequences coding polypeptide for use in carotenoid biosynthesis
05/29/2003US20030100039 Novel human phospholipase c delta 5
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity
05/29/2003US20030099992 Genes associated with mast cell activation
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099643 Methods for selectively stimulating proliferation of t cells
05/29/2003US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099623 Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
05/29/2003US20030099622 Administering a cell transplant from a donor to a recipient along with a mildly myeloablative conditioning treatment and an immune blockade treatment; prevents risk of profound neutropenia or graft-versus-host-disease (GVHD)